Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-23-002404
Filing Date
2023-07-13
Accepted
2023-07-13 15:26:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2889
  Complete submission text file 0001959173-23-002404.txt   4296
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Subject) CIK: 0001528115 (see all company filings)

EIN.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-39402 | Film No.: 231086662
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANNEXON, INC. 180 KIMBALL WAY, SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address
Overdorf Michael (Reporting) CIK: 0001818522 (see all company filings)

Type: 144